Atlas Trials

Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer

Clinical trial NCT01284413 · COMPLETED

Trial details

NCT number
NCT01284413
Sponsor
Kansai Hepatobiliary Oncology Group
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Biliary Tract Cancer
Start date
2010-12-01
Primary completion
2012-08-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.